Keytruda received FDA approval for cancer treatment, involving Merck KGaA.
3 reports, 2 independent
Updated Jul 10
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Keytruda received FDA approval for cancer treatment, involving Merck KGaA.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Merck KGaA
German multinational science and technology company
Related events
- Experimental therapies require approval from the FDA.
- Merck is seeking FDA approval for its drug Winrevair, based on data from the ZENITH, HYPERION, and Stellar studies.
- Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.
- Inventiva seeks FDA approval for lanifibranor in the U.S. market.